Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) - Global Forecast to 2027
The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps.
However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.
“Services segment is expected to grow at the highest rate during the forecast period”
On basis of components, the patient engagement solutions market is segmented into software, hardware, and services. The software segment accounted for the largest share of the global patient engagement solutions market in 2021. The software market is further segmented into standalone solutions and integrated solutions. In 2021, the integrated solutions segment has accounted for the larger share of this market & is also expected to grow at the highest CAGR during the forecast period.
However, the services segment is expected to grow at the highest CAGR during the forecast period. The high growth of the services segment can be attributed to the services being indispensable for the application of deployed solutions.
“The On-premise solutions segment is estimated to account for the largest share of the Patient Engagement Solutions market in 2022”
Based on delivery mode, the patient engagement solutions market is segmented into on-premise and cloud-based solutions. In 2021, the on-premise solutions segment accounted for the largest share of the global patient engagement solutions market. However, the cloud-based solutions segment is expected to register the highest CAGR during the forecast period. The flexibility, scalability, and affordability are the features offered by cloud-based solutions that are supporting its growth in the patient engagement solutions market.
“Health management segment in the applications accounted for the largest share of the global patient engagement solutions market”
Based on application, the patient engagement solutions market is segmented into health management, home health management, social and behavioral management, and financial health management. The health management applications segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increased awareness among patients about the health conditions cause by severe diseases and their willingness to actively participate in maintaining their own health.
“Chronic diseases among the therapeutic areas accounted for the largest share of the global patient engagement solutions market”
Based on the therapeutic area, the patient engagement solutions market is segmented into chronic diseases, women’s health, fitness, and other therapeutic areas. The chronic diseases segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increase in various chronic diseases and the need to manage these conditions with reduced healthcare costs.
“The E- Prescribing functionality is expected to grow with the highest CAGR during the forecast period”
Based on functionality, the patient engagement solutions market is segmented into E-prescribing, virtual consultation, patient/client scheduling, and document management. The patient/client scheduling segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increasing productivity and efficient care through proper scheduling of appointments. The E- Prescribing segment is expected to grow with the highest CAGR during the forecast period
“Providers' segment accounted for the largest share of the global patient engagement solutions market”
Based on end users, the patient engagement solutions market is segmented into providers, payers, patients, and other end users. The providers' segment accounted for the largest share of the global patient engagement solutions market in 2021. High adoption of patient engagement solutions to curtail rising healthcare costs, offer value-based care, and improve financial outcomes are factors that are supporting the growth of this segment. Patient engagement solutions also help providers to improve patient experience, meet the increasing demand for convenient access to health information, and better serve patients to self-manage their care.
“North America to dominate the patient engagement solutions market in 2022”
North America accounted for the largest share of the global patient engagement solutions market in 2021. Changing government initiatives and regulations in the region , the need to cut down on healthcare costs, the rising prevalence of chronic diseases, and the key market players operating in the region are the key factors driving the growth of the patient engagement solutions market in North America.
The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the increasing adoption of HCIT solutions and the growing prevalence of chronic diseases in the region.
Breakdown of supply-side primary interviews, by company type, designation, and region:
Research Coverage
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Patient Engagement Solutions market and provides them information on key market drivers, restraints, challenges, and opportunities.
However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.
“Services segment is expected to grow at the highest rate during the forecast period”
On basis of components, the patient engagement solutions market is segmented into software, hardware, and services. The software segment accounted for the largest share of the global patient engagement solutions market in 2021. The software market is further segmented into standalone solutions and integrated solutions. In 2021, the integrated solutions segment has accounted for the larger share of this market & is also expected to grow at the highest CAGR during the forecast period.
However, the services segment is expected to grow at the highest CAGR during the forecast period. The high growth of the services segment can be attributed to the services being indispensable for the application of deployed solutions.
“The On-premise solutions segment is estimated to account for the largest share of the Patient Engagement Solutions market in 2022”
Based on delivery mode, the patient engagement solutions market is segmented into on-premise and cloud-based solutions. In 2021, the on-premise solutions segment accounted for the largest share of the global patient engagement solutions market. However, the cloud-based solutions segment is expected to register the highest CAGR during the forecast period. The flexibility, scalability, and affordability are the features offered by cloud-based solutions that are supporting its growth in the patient engagement solutions market.
“Health management segment in the applications accounted for the largest share of the global patient engagement solutions market”
Based on application, the patient engagement solutions market is segmented into health management, home health management, social and behavioral management, and financial health management. The health management applications segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increased awareness among patients about the health conditions cause by severe diseases and their willingness to actively participate in maintaining their own health.
“Chronic diseases among the therapeutic areas accounted for the largest share of the global patient engagement solutions market”
Based on the therapeutic area, the patient engagement solutions market is segmented into chronic diseases, women’s health, fitness, and other therapeutic areas. The chronic diseases segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increase in various chronic diseases and the need to manage these conditions with reduced healthcare costs.
“The E- Prescribing functionality is expected to grow with the highest CAGR during the forecast period”
Based on functionality, the patient engagement solutions market is segmented into E-prescribing, virtual consultation, patient/client scheduling, and document management. The patient/client scheduling segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increasing productivity and efficient care through proper scheduling of appointments. The E- Prescribing segment is expected to grow with the highest CAGR during the forecast period
“Providers' segment accounted for the largest share of the global patient engagement solutions market”
Based on end users, the patient engagement solutions market is segmented into providers, payers, patients, and other end users. The providers' segment accounted for the largest share of the global patient engagement solutions market in 2021. High adoption of patient engagement solutions to curtail rising healthcare costs, offer value-based care, and improve financial outcomes are factors that are supporting the growth of this segment. Patient engagement solutions also help providers to improve patient experience, meet the increasing demand for convenient access to health information, and better serve patients to self-manage their care.
“North America to dominate the patient engagement solutions market in 2022”
North America accounted for the largest share of the global patient engagement solutions market in 2021. Changing government initiatives and regulations in the region , the need to cut down on healthcare costs, the rising prevalence of chronic diseases, and the key market players operating in the region are the key factors driving the growth of the patient engagement solutions market in North America.
The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the increasing adoption of HCIT solutions and the growing prevalence of chronic diseases in the region.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%)
- By Designation: C-level (44%), Director-level (35%), and Others (21%)
- By Region: North America (46%), Europe (26%), Asia Pacific (18%), and RoW (10%)
Research Coverage
- The report studies the Patient Engagement Solutions market based on component, delivery mode, therapeutic area, application, functionality, end user, and region
- The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
- The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total remote patient monitoring market
- The report forecasts the revenue of market segments with respect to five major regions
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Patient Engagement Solutions market and provides them information on key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.5.1 SCOPE-RELATED LIMITATIONS
1.5.2 METHODOLOGY-RELATED LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.2 PRIMARY SOURCES
2.2.1 KEY INDUSTRY INSIGHTS
2.2.2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 2 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.4 MARKET ESTIMATION
2.4.1 RESEARCH METHODOLOGY: MARKET ESTIMATION
2.4.2 APPROACH: END USER-BASED MARKET ESTIMATION
FIGURE 3 RESEARCH METHODOLOGY: MARKET ESTIMATION
2.4.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
2.4.4 PATIENT ENGAGEMENT SOLUTIONS MARKET: TOP-DOWN APPROACH
2.4.5 GROWTH FORECAST
FIGURE 4 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE LABORATORY INFORMATICS MARKET (2022–2027)
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.5 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.6 ASSUMPTIONS FOR THE STUDY
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: PATIENT ENGAGEMENT SOLUTIONS MARKET
2.8 LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
FIGURE 8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD MILLION)
FIGURE 9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027 (USD MILLION)
FIGURE 11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022 VS. 2027 (USD MILLION)
FIGURE 12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF
THE PATIENT ENGAGEMENT SOLUTIONS MARKET
4 PREMIUM INSIGHTS
4.1 PATIENT ENGAGEMENT SOLUTIONS MARKET OVERVIEW
FIGURE 14 RISING GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC
CARE DRIVE THE MARKET GROWTH
4.2 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER
FIGURE 15 PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2021
4.3 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE & COUNTRY (2021)
FIGURE 16 ON-PREMISE SOLUTIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021
4.4 GEOGRAPHICAL SNAPSHOT OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 17 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care
5.2.1.2 Increasing adoption of patient engagement solutions
5.2.1.3 Rising number of collaborations and partnerships between stakeholders
TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2022
5.2.1.4 Increasing utilization of mobile health apps
5.2.2 RESTRAINTS
5.2.2.1 Large investment requirements for healthcare infrastructure
5.2.2.2 Protection of patient information
5.2.2.3 Inadequate interoperability across healthcare providers
5.2.2.4 Shortage of skilled IT professionals in the healthcare industry
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging markets
5.2.3.2 Wearable health technology
5.2.3.3 Cloud-computing solutions
5.2.4 CHALLENGES
5.2.4.1 High deployments costs of healthcare IT systems
5.2.4.2 Low levels of healthcare literacy
5.3 IMPACT OF COVID-19 ON THE PATIENT ENGAGEMENT SOLUTIONS MARKET
5.4 CASE STUDIES
5.4.1 FOCUS ON REDUCING READMISSION RATES AND IMPROVING CARE
5.4.1.1 Case 1: Need to reduce patient hospital stays
5.4.2 IMPROVE OUTPATIENT COMMUNICATION
5.4.2.1 Case 2: Rising need to curb miscommunication with discharged patients
5.4.3 PATIENT ENGAGEMENT STRATEGY
5.4.3.1 Case 3: Post-discharge care
5.5 ECOSYSTEM ANALYSIS
FIGURE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
5.6 TECHNOLOGY ANALYSIS
TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
5.7 REGULATORY ANALYSIS
5.7.1 HEALTH INSURANCE PORTABILITY AND
ACCOUNTABILITY ACT OF 1996 (HIPAA)
5.7.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
5.7.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
5.7.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
5.7.5 CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA
5.7.6 AFFORDABLE CARE ACT, 2010
5.8 PRICING ANALYSIS
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 PATIENT ENGAGEMENT SOLUTION MARKET:
PORTER’S FIVE FORCES ANALYSIS
5.10 INDUSTRY TRENDS
5.10.1 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS
5.10.2 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
5.10.3 GROWING DEMAND FOR VALUE-BASED HEALTHCARE
6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT
6.1 INTRODUCTION
TABLE 5 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
6.2 HARDWARE
6.2.1 HARDWARE SOLUTIONS ARE AN INTERACTIVE EXPERIENCE
FOR PATIENTS & FAMILIES
TABLE 6 HARDWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 SOFTWARE
TABLE 7 SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 8 SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.3.1 STANDALONE SOFTWARE
6.3.1.1 Standalone software refers to the traditional
software installed in client systems
TABLE 9 STANDALONE SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.2 INTEGRATED SOFTWARE
6.3.2.1 Reduction in time spent on data management is driving the growth of this segment
TABLE 10 INTEGRATED SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 SERVICES
6.4.1 THE SERVICES SEGMENT IS EXPECTED TO WITNESS
THE HIGHEST GROWTH IN THE FORECAST PERIOD
TABLE 11 SERVICES MARKET, BY REGION, 2020–2027(USD MILLION)
7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE
7.1 INTRODUCTION
TABLE 12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
7.2 ON-PREMISE MODE
7.2.1 PATIENT DATA SAFETY AND COST BENEFITS OF
ON-PREMISE DELIVERY MODES TO DRIVE THE MARKET GROWTH
TABLE 13 ON-PREMISE MODE MARKET, BY REGION, 2020–2027(USD MILLION)
7.3 CLOUD-BASED MODE
7.3.1 REGULATORY REQUIREMENTS HAVE DRIVEN HEALTHCARE PROVIDERS
TO ADOPT CLOUD-BASED SOLUTIONS
TABLE 14 CLOUD-BASED MODE MARKET, BY REGION, 2020–2027(USD MILLION)
8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 15 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027(USD MILLION)
8.2 HEALTH MANAGEMENT
8.2.1 HEALTH MANAGEMENT PLAYS A CRUCIAL TOOL
IN GUIDING PATIENTS IN SELF-CARE
TABLE 16 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY REGION, 2020–2027(USD MILLION)
8.3 HOME HEALTH MANAGEMENT
8.3.1 GROWING PREFERENCE FOR HOME HEALTHCARE TO SUPPORT
THE MARKET GROWTH
TABLE 17 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY REGION, 2020–2027(USD MILLION)
8.4 SOCIAL & BEHAVIORAL MANAGEMENT
8.4.1 GROWING POPULARITY OF SOCIAL MEDIA TO DRIVE THE MARKET GROWTH
TABLE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY REGION, 2020–2027(USD MILLION)
8.5 FINANCIAL HEALTH MANAGEMENT
8.5.1 FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS
TABLE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2020–2027(USD MILLION)
9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA
9.1 INTRODUCTION
TABLE 20 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
9.2 CHRONIC DISEASES
TABLE 21 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2020–2027 (USD MILLION)
TABLE 22 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2020–2027 (USD MILLION)
9.2.1 CARDIOVASCULAR DISEASES (CVD)
9.2.1.1 CVD is the leading cause of death worldwide
TABLE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CVD, BY REGION, 2020–2027 (USD MILLION)
9.2.2 DIABETES
9.2.2.1 The high incidence of diabetes worldwide drives the growth of this segment
TABLE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION, 2020–2027 (USD MILLION)
9.2.3 OBESITY
9.2.3.1 Rising prevalence of obesity to drive the growth of this segment
TABLE 25 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2020–2027 (USD MILLION)
9.2.4 OTHER CHRONIC DISEASES
TABLE 26 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2020–2027 (USD MILLION)
9.3 WOMEN’S HEALTH
9.3.1 INCREASING SELF AWARENESS FOR THE MANAGEMENT OF
DISEASES TO DRIVE THE MARKET GROWTH
TABLE 27 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY REGION, 2020–2027 (USD MILLION)
9.4 FITNESS
9.4.1 GROWING PREFERENCE FOR A HEALTHY LIFESTYLE TO SUPPORT THE MARKET GROWTH FOR FITNESS-RELATED APPS
TABLE 28 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY REGION, 2020–2027 (USD MILLION)
9.5 OTHER THERAPEUTIC AREAS
TABLE 29 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2020–2027 (USD MILLION)
10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY
10.1 INTRODUCTION
TABLE 30 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
10.1.1 E-PRESCRIBING
10.1.1.1 E-prescribing is a cost-effective method of providing valuable information to clinicians to enhance decision-making
TABLE 31 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY REGION, 2020–2027 (USD MILLION)
10.1.2 VIRTUAL CONSULTATION
10.1.2.1 Telehealth provides flexibility in treatment options due to remote monitoring
TABLE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR VIRTUAL CONSULTATION, BY REGION, 2020–2027 (USD MILLION)
10.1.3 PATIENT/CLIENT SCHEDULING
10.1.3.1 Patient/client scheduling enables physicians to streamline workflows and efficiently manage patient schedules
TABLE 33 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2020–2027 (USD MILLION)
10.1.4 DOCUMENT MANAGEMENT
10.1.4.1 The effective management of patient documents is crucial for healthcare providers
TABLE 34 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2020–2027 (USD MILLION)
11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER
11.1 INTRODUCTION
TABLE 35 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2 PROVIDERS
11.2.1 PROVIDERS ARE THE LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS
TABLE 36 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2020–2027 (USD MILLION)
11.3 PAYERS
11.3.1 PATIENT ENGAGEMENT SOLUTIONS HELP HEALTHCARE
PAYERS MINIMIZE ERRORS
TABLE 37 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2020–2027 (USD MILLION)
11.4 PATIENTS
11.4.1 PATIENT ENGAGEMENT SOLUTIONS MOTIVATE INDIVIDUALS
TO MONITOR & IMPROVE HEALTH OUTCOMES
TABLE 38 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY REGION, 2020–2027 (USD MILLION)
11.5 OTHER END USERS
TABLE 39 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION
12.1 INTRODUCTION
TABLE 40 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2020–2027(USD MILLION)
12.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
TABLE 41 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
12.2.1 US
12.2.1.1 The US is the largest market in North America for patient engagement solutions in 2022
TABLE 48 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 49 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 50 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 51 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 52 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.2.2 CANADA
12.2.2.1 Growing need for cost containment to propel the
market growth in Canada
TABLE 53 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 54 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 55 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 56 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 57 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3 EUROPE
TABLE 58 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 59 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 60 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
TABLE 64 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027(USD MILLION)
12.3.1 GERMANY
12.3.1.1 Germany is the largest market for patient engagement solutions in Europe in 2022
TABLE 65 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 66 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 67 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 68 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 69 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3.2 FRANCE
12.3.2.1 Digital health insurance startups in France to drive the market growth for patient engagement solutions
TABLE 70 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 71 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 72 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 73 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 74 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3.3 UK
12.3.3.1 Favorable government initiatives to promote healthcare to support market growth in the UK
TABLE 75 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 76 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 77 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 78 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 79 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3.4 SPAIN
12.3.4.1 Data security concerns restrict the market growth in Spain
TABLE 80 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 81 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 82 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 83 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 84 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3.5 ITALY
12.3.5.1 The growing burden of chronic diseases in Italy drives the demand for patient engagement solutions
TABLE 85 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 86 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 87 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 88 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 89 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3.6 REST OF EUROPE (ROE)
TABLE 90 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 91 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 92 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 93 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 94 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 21 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
TABLE 95 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 96 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 97 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
TABLE 98 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 99 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 100 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
TABLE 101 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
12.4.1 JAPAN
12.4.1.1 The rising geriatric population in Japan supports the market growth for patient engagement solutions
TABLE 102 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 103 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 104 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 105 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 106 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.4.2 CHINA
12.4.2.1 Implementation of EMR solutions in healthcare by the Chinese government is expected to drive the demand for patient engagement solutions
TABLE 107 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 108 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 109 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 110 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 USD MILLION)
TABLE 111 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027(USD MILLION)
12.4.3 INDIA
12.4.3.1 High burden of chronic diseases to support the market growth for patient engagement solutions
TABLE 112 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 113 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 114 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 115 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 116 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 117 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 118 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
TABLE 119 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 120 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027(USD MILLION)
TABLE 121 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027(USD MILLION)
12.5 REST OF THE WORLD
TABLE 122 REST OF THE WORLD: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 123 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 124 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
TABLE 125 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 126 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 127 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
TABLE 128 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
12.5.1 LATIN AMERICA
12.5.1.1 Developments in healthcare infrastructure to support the market growth
TABLE 129 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 130 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 131 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 132 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 133 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.5.2 MIDDLE EAST & AFRICA
12.5.2.1 Rising government support to drive the market growth for patient engagement solutions in the MEA
TABLE 134 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 135 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027(USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 138 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET
13.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 22 REVENUE ANALYSIS OF KEY PLAYERS IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET
13.4 MARKET RANKING
FIGURE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET RANKING, BY KEY PLAYER, 2021
13.5 COMPETITIVE BENCHMARKING
TABLE 139 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 140 PATIENT ENGAGEMENT SOLUTIONS MARKET: DETAILED LIST
OF KEY STARTUP/SMES
13.6 COMPETITIVE LEADERSHIP MAPPING
13.6.1 STARS
13.6.2 EMERGING LEADERS
13.6.3 PERVASIVE PLAYERS
13.6.4 PARTICIPANTS
FIGURE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
13.7 COMPETITIVE LEADERSHIP MAPPING – START-UP/SME
13.7.1 PROGRESSIVE COMPANIES
13.7.2 STARTING BLOCKS
13.7.3 RESPONSIVE COMPANIES
13.7.4 DYNAMIC COMPANIES
FIGURE 25 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET
13.8 COMPETITIVE SITUATIONS AND TRENDS
13.8.1 PRODUCT LAUNCHES
13.8.2 DEALS
14 COMPANY PROFILES
14.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 IBM
TABLE 141 IBM: BUSINESS OVERVIEW
FIGURE 26 IBM: COMPANY SNAPSHOT (2021)
14.1.2 MCKESSON CORPORATION
TABLE 142 MCKESSON CORPORATION: BUSINESS OVERVIEW
FIGURE 27 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
14.1.3 ALLSCRIPTS HEALTHCARE SOLUTIONS INC
TABLE 143 ALLSCRIPTS HEALTHCARE SOLUTIONS INC: BUSINESS OVERVIEW
FIGURE 28 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
14.1.4 ATHENAHEALTH
TABLE 144 ATHENAHEALTH: BUSINESS OVERVIEW
14.1.5 ORION HEALTH
TABLE 145 ORION HEALTH: BUSINESS OVERVIEW
14.1.6 CERNER CORPORATION
TABLE 146 CERNER: BUSINESS OVERVIEW
FIGURE 29 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
14.1.7 GETWELLNETWORK, INC.
TABLE 147 GETWELL NETWORK INC: BUSINESS OVERVIEW
14.1.8 LINCOR SOLUTIONS
TABLE 148 LINCOR SOLUTIONS: BUSINESS OVERVIEW
14.1.9 COGNIZANT
TABLE 149 COGNIZANT: BUSINESS OVERVIEW
FIGURE 30 COGNIZANT: COMPANY SNAPSHOT (2020)
14.1.10 HARRIS HEALTHCARE
TABLE 150 HARRIS HEALTHCARE: BUSINESS OVERVIEW
14.2 OTHER KEY PLAYERS
14.2.1 GET REAL HEALTH
14.2.2 ONEVIEW HEALTHCARE
14.2.3 ADVANCEDMD
14.2.4 EPIC SYSTEMS CORPORATION
14.2.5 MEDITECH
14.2.6 KAREO
14.2.7 ECLINICAL WORKS
14.2.8 WELLSTACK
14.2.9 IQVIA
14.2.10 VIVIFY HEALTH
14.2.11 MEDHOST
14.2.12 VALIDIC
14.2.13 CUREMD HEALTHCARE
14.2.14 MEDISYSINC.COM
14.2.15 PATIENTPOINT, LLC
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 AVAILABLE CUSTOMIZATIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.5.1 SCOPE-RELATED LIMITATIONS
1.5.2 METHODOLOGY-RELATED LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.2 PRIMARY SOURCES
2.2.1 KEY INDUSTRY INSIGHTS
2.2.2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 2 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.4 MARKET ESTIMATION
2.4.1 RESEARCH METHODOLOGY: MARKET ESTIMATION
2.4.2 APPROACH: END USER-BASED MARKET ESTIMATION
FIGURE 3 RESEARCH METHODOLOGY: MARKET ESTIMATION
2.4.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
2.4.4 PATIENT ENGAGEMENT SOLUTIONS MARKET: TOP-DOWN APPROACH
2.4.5 GROWTH FORECAST
FIGURE 4 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE LABORATORY INFORMATICS MARKET (2022–2027)
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.5 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.6 ASSUMPTIONS FOR THE STUDY
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: PATIENT ENGAGEMENT SOLUTIONS MARKET
2.8 LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
FIGURE 8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD MILLION)
FIGURE 9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027 (USD MILLION)
FIGURE 11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022 VS. 2027 (USD MILLION)
FIGURE 12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF
THE PATIENT ENGAGEMENT SOLUTIONS MARKET
4 PREMIUM INSIGHTS
4.1 PATIENT ENGAGEMENT SOLUTIONS MARKET OVERVIEW
FIGURE 14 RISING GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC
CARE DRIVE THE MARKET GROWTH
4.2 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER
FIGURE 15 PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2021
4.3 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE & COUNTRY (2021)
FIGURE 16 ON-PREMISE SOLUTIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021
4.4 GEOGRAPHICAL SNAPSHOT OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 17 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care
5.2.1.2 Increasing adoption of patient engagement solutions
5.2.1.3 Rising number of collaborations and partnerships between stakeholders
TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2022
5.2.1.4 Increasing utilization of mobile health apps
5.2.2 RESTRAINTS
5.2.2.1 Large investment requirements for healthcare infrastructure
5.2.2.2 Protection of patient information
5.2.2.3 Inadequate interoperability across healthcare providers
5.2.2.4 Shortage of skilled IT professionals in the healthcare industry
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging markets
5.2.3.2 Wearable health technology
5.2.3.3 Cloud-computing solutions
5.2.4 CHALLENGES
5.2.4.1 High deployments costs of healthcare IT systems
5.2.4.2 Low levels of healthcare literacy
5.3 IMPACT OF COVID-19 ON THE PATIENT ENGAGEMENT SOLUTIONS MARKET
5.4 CASE STUDIES
5.4.1 FOCUS ON REDUCING READMISSION RATES AND IMPROVING CARE
5.4.1.1 Case 1: Need to reduce patient hospital stays
5.4.2 IMPROVE OUTPATIENT COMMUNICATION
5.4.2.1 Case 2: Rising need to curb miscommunication with discharged patients
5.4.3 PATIENT ENGAGEMENT STRATEGY
5.4.3.1 Case 3: Post-discharge care
5.5 ECOSYSTEM ANALYSIS
FIGURE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
5.6 TECHNOLOGY ANALYSIS
TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
5.7 REGULATORY ANALYSIS
5.7.1 HEALTH INSURANCE PORTABILITY AND
ACCOUNTABILITY ACT OF 1996 (HIPAA)
5.7.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
5.7.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
5.7.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
5.7.5 CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA
5.7.6 AFFORDABLE CARE ACT, 2010
5.8 PRICING ANALYSIS
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 PATIENT ENGAGEMENT SOLUTION MARKET:
PORTER’S FIVE FORCES ANALYSIS
5.10 INDUSTRY TRENDS
5.10.1 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS
5.10.2 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
5.10.3 GROWING DEMAND FOR VALUE-BASED HEALTHCARE
6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT
6.1 INTRODUCTION
TABLE 5 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
6.2 HARDWARE
6.2.1 HARDWARE SOLUTIONS ARE AN INTERACTIVE EXPERIENCE
FOR PATIENTS & FAMILIES
TABLE 6 HARDWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 SOFTWARE
TABLE 7 SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 8 SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.3.1 STANDALONE SOFTWARE
6.3.1.1 Standalone software refers to the traditional
software installed in client systems
TABLE 9 STANDALONE SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.2 INTEGRATED SOFTWARE
6.3.2.1 Reduction in time spent on data management is driving the growth of this segment
TABLE 10 INTEGRATED SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 SERVICES
6.4.1 THE SERVICES SEGMENT IS EXPECTED TO WITNESS
THE HIGHEST GROWTH IN THE FORECAST PERIOD
TABLE 11 SERVICES MARKET, BY REGION, 2020–2027(USD MILLION)
7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE
7.1 INTRODUCTION
TABLE 12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
7.2 ON-PREMISE MODE
7.2.1 PATIENT DATA SAFETY AND COST BENEFITS OF
ON-PREMISE DELIVERY MODES TO DRIVE THE MARKET GROWTH
TABLE 13 ON-PREMISE MODE MARKET, BY REGION, 2020–2027(USD MILLION)
7.3 CLOUD-BASED MODE
7.3.1 REGULATORY REQUIREMENTS HAVE DRIVEN HEALTHCARE PROVIDERS
TO ADOPT CLOUD-BASED SOLUTIONS
TABLE 14 CLOUD-BASED MODE MARKET, BY REGION, 2020–2027(USD MILLION)
8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 15 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027(USD MILLION)
8.2 HEALTH MANAGEMENT
8.2.1 HEALTH MANAGEMENT PLAYS A CRUCIAL TOOL
IN GUIDING PATIENTS IN SELF-CARE
TABLE 16 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY REGION, 2020–2027(USD MILLION)
8.3 HOME HEALTH MANAGEMENT
8.3.1 GROWING PREFERENCE FOR HOME HEALTHCARE TO SUPPORT
THE MARKET GROWTH
TABLE 17 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY REGION, 2020–2027(USD MILLION)
8.4 SOCIAL & BEHAVIORAL MANAGEMENT
8.4.1 GROWING POPULARITY OF SOCIAL MEDIA TO DRIVE THE MARKET GROWTH
TABLE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY REGION, 2020–2027(USD MILLION)
8.5 FINANCIAL HEALTH MANAGEMENT
8.5.1 FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS
TABLE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2020–2027(USD MILLION)
9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA
9.1 INTRODUCTION
TABLE 20 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
9.2 CHRONIC DISEASES
TABLE 21 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2020–2027 (USD MILLION)
TABLE 22 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2020–2027 (USD MILLION)
9.2.1 CARDIOVASCULAR DISEASES (CVD)
9.2.1.1 CVD is the leading cause of death worldwide
TABLE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CVD, BY REGION, 2020–2027 (USD MILLION)
9.2.2 DIABETES
9.2.2.1 The high incidence of diabetes worldwide drives the growth of this segment
TABLE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION, 2020–2027 (USD MILLION)
9.2.3 OBESITY
9.2.3.1 Rising prevalence of obesity to drive the growth of this segment
TABLE 25 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2020–2027 (USD MILLION)
9.2.4 OTHER CHRONIC DISEASES
TABLE 26 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2020–2027 (USD MILLION)
9.3 WOMEN’S HEALTH
9.3.1 INCREASING SELF AWARENESS FOR THE MANAGEMENT OF
DISEASES TO DRIVE THE MARKET GROWTH
TABLE 27 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY REGION, 2020–2027 (USD MILLION)
9.4 FITNESS
9.4.1 GROWING PREFERENCE FOR A HEALTHY LIFESTYLE TO SUPPORT THE MARKET GROWTH FOR FITNESS-RELATED APPS
TABLE 28 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY REGION, 2020–2027 (USD MILLION)
9.5 OTHER THERAPEUTIC AREAS
TABLE 29 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2020–2027 (USD MILLION)
10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY
10.1 INTRODUCTION
TABLE 30 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
10.1.1 E-PRESCRIBING
10.1.1.1 E-prescribing is a cost-effective method of providing valuable information to clinicians to enhance decision-making
TABLE 31 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY REGION, 2020–2027 (USD MILLION)
10.1.2 VIRTUAL CONSULTATION
10.1.2.1 Telehealth provides flexibility in treatment options due to remote monitoring
TABLE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR VIRTUAL CONSULTATION, BY REGION, 2020–2027 (USD MILLION)
10.1.3 PATIENT/CLIENT SCHEDULING
10.1.3.1 Patient/client scheduling enables physicians to streamline workflows and efficiently manage patient schedules
TABLE 33 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2020–2027 (USD MILLION)
10.1.4 DOCUMENT MANAGEMENT
10.1.4.1 The effective management of patient documents is crucial for healthcare providers
TABLE 34 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2020–2027 (USD MILLION)
11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER
11.1 INTRODUCTION
TABLE 35 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2 PROVIDERS
11.2.1 PROVIDERS ARE THE LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS
TABLE 36 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2020–2027 (USD MILLION)
11.3 PAYERS
11.3.1 PATIENT ENGAGEMENT SOLUTIONS HELP HEALTHCARE
PAYERS MINIMIZE ERRORS
TABLE 37 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2020–2027 (USD MILLION)
11.4 PATIENTS
11.4.1 PATIENT ENGAGEMENT SOLUTIONS MOTIVATE INDIVIDUALS
TO MONITOR & IMPROVE HEALTH OUTCOMES
TABLE 38 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY REGION, 2020–2027 (USD MILLION)
11.5 OTHER END USERS
TABLE 39 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION
12.1 INTRODUCTION
TABLE 40 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2020–2027(USD MILLION)
12.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
TABLE 41 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
12.2.1 US
12.2.1.1 The US is the largest market in North America for patient engagement solutions in 2022
TABLE 48 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 49 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 50 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 51 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 52 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.2.2 CANADA
12.2.2.1 Growing need for cost containment to propel the
market growth in Canada
TABLE 53 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 54 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 55 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 56 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 57 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3 EUROPE
TABLE 58 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 59 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 60 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
TABLE 64 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027(USD MILLION)
12.3.1 GERMANY
12.3.1.1 Germany is the largest market for patient engagement solutions in Europe in 2022
TABLE 65 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 66 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 67 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 68 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 69 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3.2 FRANCE
12.3.2.1 Digital health insurance startups in France to drive the market growth for patient engagement solutions
TABLE 70 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 71 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 72 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 73 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 74 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3.3 UK
12.3.3.1 Favorable government initiatives to promote healthcare to support market growth in the UK
TABLE 75 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 76 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 77 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 78 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 79 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3.4 SPAIN
12.3.4.1 Data security concerns restrict the market growth in Spain
TABLE 80 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 81 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 82 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 83 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 84 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3.5 ITALY
12.3.5.1 The growing burden of chronic diseases in Italy drives the demand for patient engagement solutions
TABLE 85 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 86 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 87 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 88 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 89 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.3.6 REST OF EUROPE (ROE)
TABLE 90 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 91 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 92 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 93 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 94 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 21 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
TABLE 95 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 96 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 97 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
TABLE 98 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 99 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 100 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
TABLE 101 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
12.4.1 JAPAN
12.4.1.1 The rising geriatric population in Japan supports the market growth for patient engagement solutions
TABLE 102 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 103 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 104 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 105 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 106 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.4.2 CHINA
12.4.2.1 Implementation of EMR solutions in healthcare by the Chinese government is expected to drive the demand for patient engagement solutions
TABLE 107 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 108 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 109 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 110 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 USD MILLION)
TABLE 111 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027(USD MILLION)
12.4.3 INDIA
12.4.3.1 High burden of chronic diseases to support the market growth for patient engagement solutions
TABLE 112 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 113 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 114 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 115 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 116 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 117 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 118 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
TABLE 119 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 120 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027(USD MILLION)
TABLE 121 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027(USD MILLION)
12.5 REST OF THE WORLD
TABLE 122 REST OF THE WORLD: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 123 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 124 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
TABLE 125 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 126 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 127 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
TABLE 128 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
12.5.1 LATIN AMERICA
12.5.1.1 Developments in healthcare infrastructure to support the market growth
TABLE 129 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 130 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 131 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 132 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 133 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
12.5.2 MIDDLE EAST & AFRICA
12.5.2.1 Rising government support to drive the market growth for patient engagement solutions in the MEA
TABLE 134 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 135 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027(USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 138 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET
13.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 22 REVENUE ANALYSIS OF KEY PLAYERS IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET
13.4 MARKET RANKING
FIGURE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET RANKING, BY KEY PLAYER, 2021
13.5 COMPETITIVE BENCHMARKING
TABLE 139 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 140 PATIENT ENGAGEMENT SOLUTIONS MARKET: DETAILED LIST
OF KEY STARTUP/SMES
13.6 COMPETITIVE LEADERSHIP MAPPING
13.6.1 STARS
13.6.2 EMERGING LEADERS
13.6.3 PERVASIVE PLAYERS
13.6.4 PARTICIPANTS
FIGURE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
13.7 COMPETITIVE LEADERSHIP MAPPING – START-UP/SME
13.7.1 PROGRESSIVE COMPANIES
13.7.2 STARTING BLOCKS
13.7.3 RESPONSIVE COMPANIES
13.7.4 DYNAMIC COMPANIES
FIGURE 25 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET
13.8 COMPETITIVE SITUATIONS AND TRENDS
13.8.1 PRODUCT LAUNCHES
13.8.2 DEALS
14 COMPANY PROFILES
14.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 IBM
TABLE 141 IBM: BUSINESS OVERVIEW
FIGURE 26 IBM: COMPANY SNAPSHOT (2021)
14.1.2 MCKESSON CORPORATION
TABLE 142 MCKESSON CORPORATION: BUSINESS OVERVIEW
FIGURE 27 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
14.1.3 ALLSCRIPTS HEALTHCARE SOLUTIONS INC
TABLE 143 ALLSCRIPTS HEALTHCARE SOLUTIONS INC: BUSINESS OVERVIEW
FIGURE 28 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
14.1.4 ATHENAHEALTH
TABLE 144 ATHENAHEALTH: BUSINESS OVERVIEW
14.1.5 ORION HEALTH
TABLE 145 ORION HEALTH: BUSINESS OVERVIEW
14.1.6 CERNER CORPORATION
TABLE 146 CERNER: BUSINESS OVERVIEW
FIGURE 29 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
14.1.7 GETWELLNETWORK, INC.
TABLE 147 GETWELL NETWORK INC: BUSINESS OVERVIEW
14.1.8 LINCOR SOLUTIONS
TABLE 148 LINCOR SOLUTIONS: BUSINESS OVERVIEW
14.1.9 COGNIZANT
TABLE 149 COGNIZANT: BUSINESS OVERVIEW
FIGURE 30 COGNIZANT: COMPANY SNAPSHOT (2020)
14.1.10 HARRIS HEALTHCARE
TABLE 150 HARRIS HEALTHCARE: BUSINESS OVERVIEW
14.2 OTHER KEY PLAYERS
14.2.1 GET REAL HEALTH
14.2.2 ONEVIEW HEALTHCARE
14.2.3 ADVANCEDMD
14.2.4 EPIC SYSTEMS CORPORATION
14.2.5 MEDITECH
14.2.6 KAREO
14.2.7 ECLINICAL WORKS
14.2.8 WELLSTACK
14.2.9 IQVIA
14.2.10 VIVIFY HEALTH
14.2.11 MEDHOST
14.2.12 VALIDIC
14.2.13 CUREMD HEALTHCARE
14.2.14 MEDISYSINC.COM
14.2.15 PATIENTPOINT, LLC
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 AVAILABLE CUSTOMIZATIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
